Skip to Content

Clinical Trials Details

CTSU E5508

Patient Information

CTSU E5508 - A Randomized Phase III Study of Maintenance Therapy with Bevacizumab, Pemetrexed, or a Combination of Bevacizumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLC.

View more information on clinical trial - CTSU E5508

Study Number
CTSU E5508

Clinical Trial Categories

  • Lung Cancer - Metastatic


  • Cone Health Cancer Center at Wesley Long
    501 N. Elam Avenue
    Greensboro, NC 27403
    Main: 336-832-1100

Also in this Section